Trade Names: | |
Synonyms: | |
Status: | Approved (1992) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | D11AX10 |
UNII: | 57GNO57U7G |
InChI Key | DBEPLOCGEIEOCV-WSBQPABSSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C23H36N2O2 |
Molecular Weight | 372.55 |
AlogP | 3.81 |
Hydrogen Bond Acceptor | 2.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 1.0 |
Polar Surface Area | 58.2 |
Molecular species | NEUTRAL |
Aromatic Rings | 0.0 |
Heavy Atoms | 27.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Steroid 5-alpha-reductase 2 inhibitor | DailyMed |
Primary Target | |
---|---|
steroid 5 alpha-reductase 2 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Oxidoreductase
|
- | 0-60 | - | 100-366 | 4-5 | |
Enzyme
|
- | 0-60 | - | 100-366 | 4-5 | |
Transporter
Primary active transporter
ATP-binding cassette
ABCB subfamily
|
- | 28200-28200 | - | - | - | |
Transporter
Primary active transporter
ATP-binding cassette
ABCC subfamily
|
- | 51000 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Alopecia | 4 | D000505 | ClinicalTrials |
Prostatic Neoplasms | 4 | D011471 | ClinicalTrials |
Acne Vulgaris | 2 | D000152 | ClinicalTrials |
Retinal Diseases | 2 | D012164 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
Hypogonadism | 1 | D007006 | ClinicalTrials |
Hyperplasia | 0 | D006965 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 98319-26-7 |
ChEBI | 5062 |
ChEMBL | CHEMBL710 |
DrugBank | DB01216 |
DrugCentral | 1171 |
EPA CompTox | DTXSID3020625 |
FDA SRS | 57GNO57U7G |
Human Metabolome Database | HMDB0001984 |
Guide to Pharmacology | 6818 |
PDB | FIT |
PharmGKB | PA449627 |
PubChem | 57363 |
SureChEMBL | SCHEMBL5509 |
ZINC | ZINC000003782599 |